Jonathan Tegge - Dec 16, 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Interim CFO
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Jonathan Tegge
Stock symbol
INM
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/19/2022, 04:04 PM
Previous filing
Dec 15, 2022
Next filing
Dec 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +1.4K $0.00 1.4K Dec 16, 2022 Common shares 1.4K $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting 1/12 per month, in arrears, for 12 months.